Clinical trials
Completed Phase 1 Amyloidosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| Boston University | 1 |
| Criterium, Inc. | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Intellia Therapeutics | 1 |
| Mayo Clinic | 1 |
| Neurimmune AG | 1 |
| Proclara Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloidosis | 12 |
| Immunoglobulin Light-chain Amyloidosis | 3 |
| Cardiomyopathies | 2 |
| Amyloid Neuropathies, Familial | 1 |
| Heart Failure | 1 |
| Heart Failure, Diastolic | 1 |
| Hodgkin Disease | 1 |
| Leukemia | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Multiple Myeloma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.